TXN and Alzheimer disease: Comparative analysis of samples from control and AD brains revealed a significant decrease of Trx80 immunoreactivity in AD (by 81.5% in five AD brain samples compared to four controls, p = 0.01; Fig 3A and Supporting Information Fig 1D).